United States Biotechnology & Medical Research

Larimar Therapeutics Inc (LRMR)

Track

Larimar Therapeutics Inc. recorded one insider trading transaction over the past ninety days, involving a purchase valued at $166,890. This activity follows a period where the stock price fluctuated near its fifty-two-week range. The company recently reported results financiers that exceeded expectations by 23.07%, reflecting ongoing market performance dynamics for this healthcare entity.
Ticker: LRMR Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Larimar Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 6 Jul 2026
Value US$3,742,417.68 | Price 171.20 | Shares 48,451 (-40.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-08 2026-07-06 B Purchase
3.6
Hamilton Thomas Edward
Non-Executive Director
48,451 -40.8%
171.20
US$3,742,418 		48,451 -40.8% 171.20 US$3,742,418
2026-03-02 2026-02-27 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
58,659 +6.6%
269.91
US$3,557,637 		58,659 +6.6% 269.91 US$3,557,637
2026-03-02 2026-02-27 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
34,297 +37.6%
227.16
US$848,474 		34,297 +37.6% 227.16 US$848,474
2026-03-02 2026-02-27 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
1,084,012 +11.4%
5.00
US$5,420,060 		1,084,012 +11.4% 5.00 US$5,420,060
2026-03-02 2026-02-27 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
1,084,010 +11.4%
5.00
US$5,420,050 		1,084,010 +11.4% 5.00 US$5,420,050
2026-03-02 2026-02-27 B Purchase
1.4
THOMAS FRANK E
Non-Executive Director
5,000 +250.0%
5.00
US$25,000 		5,000 +250.0% 5.00 US$25,000
2026-03-02 2026-02-27 B Purchase
3.0
SHERMAN JEFFREY W
Non-Executive Director
5,000 +inf%
5.00
US$25,000 		5,000 +inf% 5.00 US$25,000
2026-03-02 2026-02-27 B Purchase
3.6
Hamilton Thomas Edward
Non-Executive Director
100,000 +17.7%
5.00
US$500,000 		100,000 +17.7% 5.00 US$500,000
2025-08-04 2025-07-31 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
2,599,932 +55.1%
3.20
US$8,319,782 		2,599,932 +55.1% 3.20 US$8,319,782
2025-08-04 2025-07-31 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
3,387,539 +55.1%
3.20
US$10,840,125 		3,387,539 +55.1% 3.20 US$10,840,125
2025-08-04 2025-07-31 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
3,387,529 +55.1%
3.20
US$10,840,093 		3,387,529 +55.1% 3.20 US$10,840,093
2024-05-31 2024-02-16 B Purchase
3.6
Hamilton Thomas Edward
Non-Executive Director
57,208 +11.3%
8.74
US$499,998 		57,208 +11.3% 8.74 US$499,998
2024-02-16 2024-02-16 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
1,430,205 +51.5%
8.74
US$12,499,992 		1,430,205 +51.5% 8.74 US$12,499,992
2024-02-16 2024-02-16 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
1,430,206 +30.3%
8.74
US$12,500,000 		1,430,206 +30.3% 8.74 US$12,500,000
2024-02-16 2024-02-16 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
1,430,206 +30.3%
8.74
US$12,500,000 		1,430,206 +30.3% 8.74 US$12,500,000
2024-02-15 2024-02-14 B Purchase
1.4
THOMAS FRANK E
Non-Executive Director
2,000 +inf%
11.00
US$22,000 		2,000 +inf% 11.00 US$22,000
2023-12-08 2023-12-07 B Purchase
3.4
Shankar Gopi

Chief Development Officer

Officer
5,000 +inf%
3.73
US$18,662 		5,000 +inf% 3.73 US$18,662
2023-07-24 2023-07-24 PrS Proposed sale
2.2
Barrett Peter

Officer

Officer
8,300
3.23
US$26,809 		8,300 3.23 US$26,809
2023-05-18 2023-05-17 B Purchase
3.5
BEN-MAIMON CAROLE

President and CEO

Executive Director
5,000 +1.9%
3.71
US$18,525 		5,000 +1.9% 3.71 US$18,525
2023-05-18 2023-05-17 B Purchase
2.2
Truitt Joseph
Non-Executive Director
2,750 +inf%
3.73
US$10,258 		2,750 +inf% 3.73 US$10,258
2023-05-18 2023-05-17 B Purchase
3.6
Celano Michael

Chief Financial Officer

Officer
5,000 +4.6%
3.73
US$18,632 		5,000 +4.6% 3.73 US$18,632
2022-09-20 2022-09-16 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
2,777,777 +inf%
3.15
US$8,749,998 		2,777,777 +inf% 3.15 US$8,749,998
2022-09-20 2022-09-16 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
2,777,777 +142.9%
3.15
US$8,749,998 		2,777,777 +142.9% 3.15 US$8,749,998
2022-09-20 2022-09-16 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
2,777,777 +142.9%
3.15
US$8,749,998 		2,777,777 +142.9% 3.15 US$8,749,998
2022-09-20 2022-09-16 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
2,777,777 +142.9%
3.15
US$8,749,998 		2,777,777 +142.9% 3.15 US$8,749,998
2022-09-20 2022-09-16 B Purchase
3.6
Hamilton Thomas Edward
Non-Executive Director
317,460 +167.0%
3.15
US$999,999 		317,460 +167.0% 3.15 US$999,999
2022-09-19 2022-09-16 B Purchase
3.5
BEN-MAIMON CAROLE

President and CEO

Executive Director
31,746 +126.6%
3.15
US$100,000 		31,746 +126.6% 3.15 US$100,000
2022-09-19 2022-09-16 B Purchase
3.6
Celano Michael

Chief Financial Officer

Officer
31,746 +inf%
3.15
US$100,000 		31,746 +inf% 3.15 US$100,000
2018-06-29 2018-06-28 PlS Planned sale Hughes Thomas E.

See Remarks

Executive Director
32,000 -20.4%
10.00
US$320,000 		32,000 -20.4% 10.00 US$320,000
2018-03-09 2018-03-07 PlS Planned sale
3.1
Hughes Thomas E.

See Remarks

Executive Director
5,000 -3.1%
10.00
US$50,000 		5,000 -3.1% 10.00 US$50,000
2017-10-17 2017-10-13 B Purchase
3.8
Heller Frances K
10,000 +26.3%
3.90
US$38,988 		10,000 +26.3% 3.90 US$38,988
2017-07-12 2017-07-11 B Purchase KIM DENNIS D

Chief Medical Officer

Officer
10,000 +87.4%
3.39
US$33,900 		10,000 +87.4% 3.39 US$33,900
2017-05-11 2017-05-11 PP Planned purchase KIM DENNIS D

Chief Medical Officer

Officer
9,800 +596.5%
4.40
US$43,120 		9,800 +596.5% 4.40 US$43,120
2017-05-11 2017-05-10 PP Planned purchase KIM DENNIS D

Chief Medical Officer

Officer
200 +13.9%
4.40
US$880 		200 +13.9% 4.40 US$880
2016-12-20 2016-12-19 B Purchase
3.8
Heller Frances K
Non-Executive Director
10,000 +50.0%
3.23
US$32,290 		10,000 +50.0% 3.23 US$32,290
2016-11-17 2016-11-15 B Purchase
3.8
Heller Frances K
Non-Executive Director
10,000 +100.0%
3.54
US$35,434 		10,000 +100.0% 3.54 US$35,434
2016-08-31 2016-08-29 B Purchase
3.1
Hughes Thomas E.

President and CEO

Executive Director
10,000 +18.5%
3.00
US$29,987 		10,000 +18.5% 3.00 US$29,987
2016-07-26 2016-07-26 PP Planned purchase
Allen Patricia L

Chief Financial Officer

Officer
8,200 +70.7%
3.15
US$25,830 		8,200 +70.7% 3.15 US$25,830
2016-07-26 2016-07-25 B Purchase Allen Patricia L

Chief Financial Officer

Officer
7,800 +205.6%
3.08
US$24,032 		7,800 +205.6% 3.08 US$24,032
2016-07-26 2016-07-22 PP Planned purchase
3.1
Hughes Thomas E.

President and CEO

Executive Director
5,000 +10.2%
3.02
US$15,104 		5,000 +10.2% 3.02 US$15,104
2016-07-26 2016-07-22 B Purchase
3.8
Heller Frances K
Non-Executive Director
10,000 +inf%
2.99
US$29,900 		10,000 +inf% 2.99 US$29,900
2016-08-01 2016-07-20 S Sale Flynn James E Large shareholder
901,430 -43.9%
3.31
US$2,985,356 		901,430 -43.9% 3.31 US$2,985,356
2016-08-01 2016-07-20 S Sale Flynn James E Large shareholder
246,439 -43.9%
3.31
US$816,157 		246,439 -43.9% 3.31 US$816,157
2016-08-01 2016-07-20 S Sale Flynn James E Large shareholder
193,630 -43.9%
3.31
US$641,264 		193,630 -43.9% 3.31 US$641,264
2016-02-17 2016-02-12 B Purchase Flynn James E Large shareholder
13,872 +0.7%
6.25
US$86,653 		13,872 +0.7% 6.25 US$86,653
2016-02-17 2016-02-12 B Purchase Flynn James E Large shareholder
28,377 +5.3%
6.25
US$177,260 		28,377 +5.3% 6.25 US$177,260
2016-02-17 2016-02-12 B Purchase Flynn James E Large shareholder
22,296 +5.3%
6.25
US$139,274 		22,296 +5.3% 6.25 US$139,274
2016-02-11 2016-02-11 B Purchase Flynn James E Large shareholder
504 +0.0%
6.19
US$3,119 		504 +0.0% 6.19 US$3,119
2016-02-11 2016-02-11 B Purchase Flynn James E Large shareholder
1,030 +0.2%
6.19
US$6,374 		1,030 +0.2% 6.19 US$6,374
2016-02-11 2016-02-11 B Purchase Flynn James E Large shareholder
810 +0.2%
6.19
US$5,013 		810 +0.2% 6.19 US$5,013
2016-02-11 2016-02-10 B Purchase Flynn James E Large shareholder
32,501 +1.6%
6.23
US$202,556 		32,501 +1.6% 6.23 US$202,556
2016-02-11 2016-02-10 B Purchase Flynn James E Large shareholder
66,486 +14.3%
6.23
US$414,361 		66,486 +14.3% 6.23 US$414,361
2016-02-11 2016-02-10 B Purchase Flynn James E Large shareholder
52,239 +14.3%
6.23
US$325,569 		52,239 +14.3% 6.23 US$325,569
2016-02-11 2016-02-09 B Purchase Flynn James E Large shareholder
24,484 +1.2%
5.73
US$140,271 		24,484 +1.2% 5.73 US$140,271
2016-02-11 2016-02-09 B Purchase Flynn James E Large shareholder
50,086 +12.1%
5.73
US$286,948 		50,086 +12.1% 5.73 US$286,948
2016-02-11 2016-02-09 B Purchase Flynn James E Large shareholder
39,353 +12.1%
5.73
US$225,457 		39,353 +12.1% 5.73 US$225,457
2015-09-25 2015-09-24 S Sale
3.4
STARR KEVIN P
Non-Executive Director
61,630 -22.7%
44.10
US$2,717,883 		61,630 -22.7% 44.10 US$2,717,883
2015-09-25 2015-09-24 S Sale
3.4
STARR KEVIN P
Non-Executive Director
74,949 -21.6%
43.73
US$3,277,520 		74,949 -21.6% 43.73 US$3,277,520
2015-09-21 2015-09-18 PlS Planned sale
3.1
Hughes Thomas E.

Chief Executive Officer

Executive Director
23,126 -96.6%
45.00
US$1,040,670 		23,126 -96.6% 45.00 US$1,040,670
2015-09-21 2015-09-17 PlS Planned sale
3.1
Hughes Thomas E.

Chief Executive Officer

Executive Director
22,500 -96.5%
40.00
US$900,000 		22,500 -96.5% 40.00 US$900,000
2015-09-21 2015-09-17 PlS Planned sale
0.8
Secor Alicia

Chief Commercial Officer

Officer
1,256 -100.0%
41.05
US$51,559 		1,256 -100.0% 41.05 US$51,559
2015-09-21 2015-09-17 PlS Planned sale
0.8
Secor Alicia

Chief Commercial Officer

Officer
25,000 -95.2%
41.05
US$1,026,250 		25,000 -95.2% 41.05 US$1,026,250
2015-09-17 2015-09-17 S Sale
3.7
KIM DENNIS D

Chief Medical Officer

Officer
9,142 -100.0%
40.00
US$365,680 		9,142 -100.0% 40.00 US$365,680
2015-09-17 2015-09-15 S Sale
3.7
KIM DENNIS D

Chief Medical Officer

Officer
30,265 -100.0%
40.00
US$1,210,600 		30,265 -100.0% 40.00 US$1,210,600
2015-09-16 2015-09-14 S Sale
3.7
KIM DENNIS D

Chief Medical Officer

Officer
593 -100.0%
40.00
US$23,720 		593 -100.0% 40.00 US$23,720
2014-06-23 2014-06-19 B Purchase
0.8
Secor Alicia

Chief Commercial Officer

Officer
4,000 +inf%
20.00
US$80,000 		4,000 +inf% 20.00 US$80,000
Explore more

More insider trading research around Larimar Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America